Cardiovascular Disease Risk in Women With Endometriosis

Launched by YALE UNIVERSITY · Nov 16, 2018

Keywords

ClinConnect Summary

This clinical trial, titled "Cardiovascular Disease Risk in Women With Endometriosis," is looking at how estrogen suppression might affect blood vessel function in women with endometriosis. Endometriosis is a condition where tissue similar to the lining inside the uterus grows outside of it, which can lead to pain and other health issues. Researchers want to understand if managing estrogen levels can improve heart health in these women.

To participate in the study, women aged 18 to 45 with or without endometriosis are eligible, but those who smoke, have diabetes, suffer from sleep apnea, or have high blood pressure will not be accepted. Participants can expect to take part in tests and assessments related to their cardiovascular health. This trial is currently recruiting, and it’s an important opportunity for women with endometriosis to contribute to our understanding of how this condition may affect their heart health.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Young women between the ages of 18 and 45 years (Controls);
• • Young women between the ages of 18 and 45 years with endometriosis.
• Exclusion Criteria:
• • Subjects who smoke
• • Subjects who have diabetes,
• • Subjects with sleep apnea or BP\>140/90 will be excluded.
• • Women with endometriosis and severe acute pain requiring immediate treatment will be excluded.